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Human diabetic pregnancy is associated with an increased vascular resistance in the maternal uteroplacental circulation. The prevalence of an abnormal uterine artery Doppler velocity waveform is much higher in diabetic than nondiabetic populations (6, 9, 39, 59) . The strongest correlation between abnormal uterine artery Doppler waveform and adverse pregnancy outcome has been reported in diabetic pregnant women with preexisting vascular complications (59) . Impaired uteroplacental blood flow was also documented in a rodent model of streptozotocin (STZ)-induced diabetes and a mouse model of gestational diabetes (14, 25, 63, 64) .
Normal pregnancy is characterized by a marked increase in uterine blood flow due to growth and remodeling of the uterine vasculature as well as enhanced endothelium-dependent uterine vasodilation (8, 33, 52, 55) . Therefore, multiple causes might be responsible for the reduced uteroplacental blood flow in diabetic pregnancies, including functional abnormalities in the maternal uteroplacental vasculature. Recent studies (4, 45, 57) have indicated that human diabetic pregnancy is associated with abnormal regulation of peripheral vascular tone resulting in part from vascular endothelial dysfunction. Impaired endothelial function was also found in the maternal peripheral vasculature of women with a previous history of gestational diabetes (2, 36) . Experimental data on the functional behavior of maternal uterine arteries in diabetic pregnancy are exceptionally limited. Endothelial dysfunction has been reported in the main uterine artery of diabetic rats and mice and myometrial arteries of diabetic pregnant women, although the underlying cellular mechanisms were not defined (16, 63, 64) . In human and rodent pregnancy, maternal uteroplacental vascular resistance is mainly regulated by the vascular tone of uterine radial arteries. These vessels connect large main and arcuate uterine arteries with spiral arteries; the latter vessels are characterized by their significant enlargement and loss of contractility due to trophoblast invasion (12, 52, 55) . The effect of experimental diabetes on endothelium-mediated vasodilation of uteroplacental radial arteries remains unexplored and was the major objective of the present study.
We hypothesized that diabetes during rat pregnancy impairs agonist-induced uterine vasodilation due to reduced smooth muscle cell (SMC) Virgin Sprague-Dawley rats (10 -11 wk of age) were purchased from Charles River Laboratories (St. Constant, QC, Canada) and housed in the animal care facility at the University of Vermont. The estrus cycle for female rats was determined by an examination of vaginal smears, and rats in proestrus were used for breeding. Female rats were bred with Sprague-Dawley male rats overnight in isolated pairs using metabolic cages. If copulative plugs were observed the following morning, that day was designated day 1 of pregnancy. On day 2 of pregnancy, female rats were anesthetized with 4% isoflurane, and 50 -55 mg/kg STZ in 1 ml citrate buffer was injected intraperitoneally. Control pregnant rats were injected with 1 ml citrate buffer. Both STZ-and citrate buffer-injected rats were weighed every 2 days. Maternal blood glucose levels were determined from a tail nick using a Freestyle glucometer every other day.
On day 20 of pregnancy, rats were euthanized with 4% isoflurane followed by decapitation. The abdominal wall was transected, and the entire uterus and uterine vasculature were rapidly removed and pinned in a dissecting dish filled with aerated cold physiological salt solution (see Solutions and drugs for the composition of PSS). Second-order uterine radial arteries were identified within the mesometrial arcade and dissected free of connective tissue. Only radial arteries feeding the placenta (uteroplacental arteries) were used for this study. Arterial segments were cannulated from both ends in the arteriograph and continuously superfused at 3 ml/min with aerated (10% O 2-5% CO2-85% N2) PSS at 37°C. Cannulated arteries were initially pressurized to 10 mmHg using the servo pressure system (Living System Instrumentation, Burlington, VT). After a 1-h equilibration period, intraluminal pressure was elevated to 50 mmHg. All experiments were performed at 50 mmHg and under no intraluminal flow conditions. Uteroplacental radial arteries from late pregnant rats can develop vasoconstriction (myogenic tone) in response to elevations of pressure exceeding 50 mmHg (32) . To avoid the development of myogenic tone and its interference with phenylephrine (PE)-induced constriction, arteries were pressurized at 50 mmHg. Radial arteries are located between the main uterine artery and placenta. Physiological levels of pressure measured in these vessels in vivo are 1/3 to 2/3 of central arterial pressure that approximate 40 -70 mmHg (52) .
Fetuses and their placentas were carefully dissected from each uterine horn and individually weighed without membranes and umbilical cords. The litter size and number of fetal resorptions were recorded for each control or diabetic rat.
Selective loading of ECs or SMCs with fura-2 and measurement of [Ca 2ϩ ]i. A detailed description of the procedure for selective loading of ECs or SMCs of uterine arteries with the Ca 2ϩ-sensitive dye fura-2 has been previously published (32) . Heat-polished glass cannulas were used in all experiments to prevent accidental damage of the endothelial layer during the cannulation procedure and to avoid diffusion of fura-2 to the SMC layer. ECs were loaded with fura-2 at room temperature by an intraluminal perfusion of pressurized arteries with fura-2 AM-containing solution (5 M) for 5 min followed by 10 min of washout with regular PSS. A similar protocol was used in our previous study (32) , where preferential loading of ECs with fura-2 was confirmed by the nearly complete disappearance of fluorescent signals after arterial denudation. SMC loading with fura-2 was performed by an extraluminal incubation of arteries in fura-2 AM (5 M)-containing solution at room temperature in the dark for 60 min. Fura-2-loaded arteries were washed two to three times and then continuously superfused with aerated PSS at 37°C. Ratiometric measurements of fura-2 fluorescence from ECs or SMCs were performed with a photomultiplier system (IonOptix, Milton, MA). Experimental ratios were corrected for background fluorescence taken from each artery before they were loaded with fura-2. Background-corrected ratios of 510-nm emission were obtained at a sampling rate of 5 Hz from arteries alternately excited at 340 and 380 nm. All experimental protocols were started after an additional 15-min equilibration period at 10 mmHg to allow the intracellular deesterification of fura-2 AM.
Measurements of SMC membrane potential from pressurized arteries. For intracellular measurements of SMC membrane potential from pressurized arteries, we used short arterial segments (400 -500 m) that had been carefully cleaned of any residual connective tissue. Glass microelectrodes were filled with 0.5M KCl and had tip resistances of 110 -150 M⍀; an Ag-AgCl pellet was used as an indifferent electrode. A microelectrode was connected to a motorized micromanipulator (World Precision Instruments), and membrane potential was recorded using a high-input impedance amplifier (Electro 705, World Precision Instruments). Changes in membrane potential and arterial diameter were simultaneously displayed and recorded on a desktop computer using a data-acquisition program (IonOptix). The following criteria were used for the acceptance of membrane potential recordings: 1) an abrupt negative change in voltage upon impalement of the cells, 2) a sharp return to zero voltage after the withdrawal of the microelectrode tip, 3) a tip potential of Ͻ7 mV, and 4) unchanged resistance of microelectrodes after impalement. A stable membrane potential recording for at least 1 min was accepted for data collection.
Enzymatic isolation of ECs and fura-2-based measurements of [Ca 2ϩ
]i from small sheets of ECs. Our protocol for the isolation of sheets of ECs from radial uteroplacental arteries was adopted from Hannah et al. (35) . After the dissection and careful cleaning from perivascular connective tissue, arterial segments were cut open and placed in dissociation media (see composition in Solutions and drugs) for 10 min at 4 -6°C. Vessels were digested in dissociation media containing neutral protease [dispase (0.5 mg/ml)] and elastase (0.5 mg/ml) for 60 min at 37°C; 0.5 mg/ml collagenase type 1 was included for the final minute. Gentle trituration of arteries with a glass pipette yielded small sheets of ECs (EC sheets) as well as single ECs. To study Ca 2ϩ responses from ECs, a suspension of EC sheets was placed into an experimental chamber. After a 15-min equilibration period and attachment of EC sheets to the glass bottom, the chamber was superfused with aerated PSS at 37°C for 20 min. Loading of ECs with fura-2 was then performed during 7-8 min at room temperature (no-flow condition) followed by washout for the next 15 min to allow the intracellular deesterification of fura-2 AM. For each experiment, fura-2 fluorescence was recorded from one individual sheet of ECs containing 21.8 Ϯ 3.2 cells (n ϭ 12). ECs were slightly elongated, with diameters of 9.6 Ϯ 0.2 m (n ϭ 49 cells; measurements were taken from microphotographs of six EC sheets).
Protocols for testing the endothelial function of uteroplacental arteries. The effects of diabetic pregnancy on uteroplacental endothelial function were evaluated based on responses of pressurized arteries to ACh. Arteries were preconstricted with PE to 50 -70% of the initial diameter. After the stabilization of vasoconstriction, ACh was applied in increasing concentrations. For each artery, dose-dependent effects of ACh were studied only once. A combination of papaverine (100 M, a phosphodiesterase inhibitor) and diltiazem (10 M, a Ca ACh-induced hyperpolarization. In our electrophysiological experiments, each artery was initially pressurized to 10 mmHg and equilibrated during 1 h. Resting membrane potential was measured from two to three different cells, and intraluminal pressure was then elevated to 50 mmHg. After membrane potential was recorded at 50 mmHg, PE was added to preconstrict arteries to 50 -70%. After stabilization of the PE-induced constriction, microelectrode impalement of SMCs was performed, and membrane potential was recorded for 2-3 min. ACh was applied in concentrations of 3 ϫ 10 Ϫ7 and 10
Ϫ6
M during the next 15-20 min. SMC membrane potential and arterial diameter were measured at 5-8 min of ACh application. A combination of papaverine and diltiazem was added at the end of each experiment to maximally dilate the artery.
Protocols for measurement of EC [Ca 2ϩ ]i responses to ACh in pressurized arteries and EC sheets.
After arteries had been loaded with fura-2, intraluminal pressure was elevated from 10 to 50 mmHg, and EC [Ca 2ϩ ]i transients were recorded in response to increasing concentrations of ACh (3 min for each dose). These experiments were performed without preconstriction of the arteries with PE as recent studies (38, 43, 53) have indicated that Ca 2ϩ and/or inositol 1,4,5-trisphosphate (IP3) elevated in response to agonist stimulation of SMCs can diffuse to ECs through myoendothelial gap junctions and modulate endothelial Ca 2ϩ signaling. In separate experiments, AChinduced EC [Ca 2ϩ ]i responses were also studied using small EC sheets enzymatically isolated from uteroplacental arteries of control and diabetic rats.
Solutions and drugs. PSS (in mM) contained 119 NaCl, 4.7 KCl, 24.0 NaHCO 3, 1.2 KH2PO4, 1.6 CaCl2, 1.2 MgSO4, 0.023 EDTA, and 11.0 glucose (pH 7.4). For the fura-2 calibration procedure, we used a solution of the following composition: 140 mM KCl, 20 mM NaCl, 5 mM HEPES, 5 mM EGTA, 1 mM MgCl 2, 5 M nigericin, and 10 M ionomycin (pH 7.1). The dissociation media for enzymatic isolation of endothelial cells contained (in mM) 55 NaCl, 80 Na glutamate, 5.9 KCl, 2 MgCl 2, 0.1 CaCl2, 5 glucose, and 10 HEPES (pH was adjusted to 7.3).
The majority of chemicals was purchased from Sigma Chemical (St. Louis, MO) with the exception of ionomycin and nigericin, which were obtained from Calbiochem (La Jolla, CA). Fura-2 AM and pluronic acid were purchased from Invitrogen (Carlsbad, CA). Protease, elastase, and collagenase were purchase from Worthington Biochemical (Lakewood, NJ). Fura-2 AM was dissolved in dehydrated DMSO as a 1 mM stock solution, refrigerated in small aliquots, and used within 1 wk of preparation. PE, ACh, and papaverine were dissolved in deionized water on the experimental day. Diltiazem and indomethacin were prepared as 10 mM stock solutions in deionized water and alcohol, respectively, and kept refrigerated until use. Ionomycin and nigericin were dissolved in ethanol (10 mM) and kept at Ϫ20°C.
Calculations and statistical analysis. EC or SMC [Ca 2ϩ ]i was calculated using the following equation (34)
, where R is the experimentally measured ratio (340/380 nm) of fluorescence intensities, Rmin is the ratio in the absence of [Ca 2ϩ ]i, Rmax is the ratio at Ca 2ϩ -saturated fura-2 conditions, and ␤ is the ratio of the fluorescence intensities at 380-nm excitation wavelength at Rmin and Rmax. Rmin, Rmax, and ␤ were determined by an in situ calibration procedure from arteries treated with ionomycin (10 M) and nigericin (5 M). Calibration was performed for two separate sets of pressurized vessels loaded intraluminally or extraluminally with fura-2. In addition, a similar calibration procedure was performed on a subset of EC sheets loaded with fura-2. These values were then pooled and used to convert the ratio values into [Ca 2ϩ ]i. Kd for fura-2 was 282 nM, as determined by the in situ titration of Ca 2ϩ in fura-2-loaded small arteries (46) . Kd for fura-2 is known to be sensitive to pH. It has been reported that after 3 wk of STZ-induced diabetes, only minor changes in basal intracellular pH (from 7.12 to 7.14) were detected in mesenteric arteries (40) . pH variations over a reasonable range of intracellular values (7.05 to 6.75) did not affect either the spectra of the Ca 2ϩ -free or Ca 2ϩ -bound species or effective Ca 2ϩ Kd for fura-2 (34). Therefore, we used the same Kd value for the conversion of experimental ratios into [Ca 2ϩ ]i concentrations for both control and diabetic vessels. Arterial diameter and intraluminal pressure in combination with membrane potential or ratios were simultaneously recorded using an IonOptix data-acquisition program and imported into the SigmaPlot program for graphical representation, calculations, and statistical analysis. In view of the significant oscillatory activity in uterine arteries, all measurements were made by averaging records of arterial diameters, membrane potential, or SMC [Ca 2ϩ ]i during 15-20 s. Data are expressed as means Ϯ SE, where each n is the number of arterial segments studied. One or two arteries from the same animal were used on each experimental day with 1 vessel/animal used for a particular protocol. A paired or unpaired Student's t-test or two-way repeated-measures ANOVA were used to determine the significance of differences between sets of data, with P value of Ͻ0.05 considered significant. The concentration of ACh required to produce half-maximal vasodilation (EC 50) was determined for each tested artery using standard curve analysis from data imported into the SigmaPlot program.
RESULTS
Maternal and fetal pregnancy outcome in a rat model of diabetic pregnancy. Maternal and fetal pregnancy outcome in a rat model of diabetic pregnancy are shown in Table 1 . STZ injection produced sustained hyperglycemia from day 4 -5 of pregnancy, with average nonfasting glucose levels at day 20 of pregnancy of 428.2 Ϯ 10.0 mg/dl. Control rats injected with citrate buffer remain normoglycemic throughout their whole pregnancy. Hyperglycemic rats gained significantly less weight during gestation than control rats. Diabetic pregnancy resulted in significantly reduced fetal weights. In contrast, placental weights and placental surface areas were significantly larger in hyperglycemic animals. There were no differences in the number of fetal resorptions (0.3 Ϯ 0.17 vs. 0.2 Ϯ 0.08) or litter size in diabetic versus control rats, respectively (P Ͼ 0.05).
Diabetes impairs endothelial function of uteroplacental arteries. Next, we evaluated the effect of experimental diabetes on AChinduced responses of arteries of control and diabetic rats. In all experiments, passive lumen diameters of uteroplacental arteries at 50 mmHg were not significantly different from initial vessel diameters before PE application in control (179.
diabetic rats. Levels of PE-induced preconstriction were comparable between the two studied groups (61.7 Ϯ 2.9% in control rats vs. 63.1 Ϯ 1.7% in diabetic rats). PE-induced constriction of both control and diabetic vessels was associated with significant SMC [Ca 2ϩ ] i elevation and the appearance of frequent SMC [Ca 2ϩ ] i transients (Fig. 1, A and B (Fig. 1A) . ACh-induced reductions in SMC [Ca 2ϩ ] i and dilator responses were significantly blunted in arteries of diabetic rats (Fig. 1B) . Figure 2 , A and B, shows the effects of diabetes on transient and sustained components of ACh-induced vasodilation. EC 50 values for ACh were significantly higher in diabetic compared with control vessels, demonstrating their decreased sensitivity to ACh (Fig. 2, C and D) .
To evaluate the role of EDHF in the diabetes-induced impairment of endothelium-dependent vasodilation, comparative experiments were performed in vessels pretreated with L-NNA and indomethacin. Application of ACh resulted in significant concentration-dependent EDHF-mediated vasodilation of control arteries. The transient vasodilation to ACh was markedly reduced and sustained ACh-induced responses were almost abolished in diabetic vessels, demonstrating the transient nature of EDHF-mediated responses (Fig. 3, A and B) . EC 50 values for ACh were significantly increased in diabetic pregnancy (Fig. 3, C and D) .
Diabetes-reduced vasodilation to ACh was associated with diminished SMC [Ca 2ϩ ] i responses in untreated arteries as well as in vessels treated with L-NNA and indomethacin (Fig. 4, A  and B) . These data suggest that the mechanisms responsible for the ACh-induced reduction in SMC [Ca 2ϩ ] i are significantly impaired by diabetes.
Experimental diabetes impairs ACh-induced hyperpolarization. Recently, we demonstrated that ACh-induced vasodilation of maternal uteroplacental arteries is associated with vascular SMC hyperpolarization (33) . Therefore, impaired ACh-induced SMC hyperpolarization may be the mechanism underlying attenuated dilator and SMC [Ca 2ϩ ] i responses in diabetic pregnancy. Measurements of SMC membrane potential were performed in pressurized arteries from control and diabetic rats. The resting membrane potential of SMCs at 10 mmHg was not different between two groups of vessels (Ϫ55.1 Ϯ 1.7 mV, n ϭ 9, in control rats vs. Ϫ53.6 Ϯ 2.1 mV, n ϭ 8, in diabetic rats, P ϭ 0.295). Elevation of intraluminal pressure from 10 to 50 mmHg produced no significant changes in the Values are means Ϯ SE; n ϭ 39 control rats and 51 diabetic rats. ] i rise to ACh are shown in Fig. 6, A and B. As shown in the summary graphs in Fig. 6 , C and D, both transient and sustained EC [Ca 2ϩ ] i elevations were reduced in vessels of diabetic rats. Similar experiments were performed on small sheets of ECs enzymatically isolated from uteroplacental arteries. At 37°C, basal levels of EC [Ca 2ϩ ] i were similar in cells from control (41.8 Ϯ 4.2 nM, n ϭ 9) and diabetic (47.8 Ϯ 5.1 nM, n ϭ 12) rats. These levels were significantly lower compared with those in pressurized vessels. ACh-induced EC [Ca 2ϩ ] i responses were blunted in EC sheets from diabetic rats (Fig. 7, A and B) . The summary graphs shown in Fig. 7 , C and D, demonstrate the significant decrease in both transient and sustained elevations in [Ca 2ϩ ] i in response to application of ACh in EC sheets of diabetic rats.
DISCUSSION
This study aimed to explore the effects of experimental diabetes in rat pregnancy on the endothelium-dependent vasodilation of maternal uteroplacental radial arteries and to determine the underlying cellular mechanisms with a specific focus on EC Ca In this study, the induction of diabetes during pregnancy was achieved by STZ-induced damage of pancreatic ␤-cells to mimic type 1 diabetes in human pregnancy. The manifestation of diabetes was confirmed by the development of marked maternal hyperglycemia during the last 2 wk of rat pregnancy. This model of diabetes aimed to mimic the development of hyperglycemia during untreated diabetic pregnancy in humans and has been previously used to explore the effects of maternal diabetes on pregnancy outcome in rodents (41) . Although this model of diabetes is short lasting, it covers most of the duration of rat pregnancy and allows us to study the effect of hyperglycemia, the most damaging factor of diabetic pregnancy, on maternal uteroplacental vascular function. In agreement with previously published findings, fetal weights were significantly decreased demonstrating fetal growth restriction in association with maternal hyperglycemia during rodent pregnancy (14, 25, ]i levels measured before the administration of ACh. *Significantly different compared with the respective control group at P Ͻ 0.05 (by two-way repeated-measures ANOVA). 58, 63) . Placental weights and placental surface areas were significantly increased in our diabetic rat model. Similar placental changes have been described in poorly controlled human diabetic pregnancy and may represent compensatory adaptations to ensure adequate nutrient and O 2 supply to the growing fetus (21) .
Both animal and human studies (14, 25, 59, 64) have provided evidence for decreased maternal uterine blood flow in pregnancies complicated by diabetes. Normal pregnancy is associated with a significant increase in maternal uterine blood flow mainly due to remodeling of the uterine vasculature and enhanced uterine vasodilation (8, 12, 52, 55 ). In our recent study (58), we found no changes in growth of maternal uterine vasculature in the rat model of STZ-induced diabetic pregnancy. This suggests that the decreased maternal uterine blood flow previously described in rat diabetic pregnancy (14, 25) may be due to abnormal functional behavior of the uteroplacental resistance vasculature.
Endothelial dysfunction is considered a key mechanism for diabetic vascular disease. There is experimental and clinical evidence for the presence of impaired endothelium-dependent vasodilation in various vascular beds of animal models of diabetes or in humans with type 1 and type 2 diabetes (18, 20, 22, 27) . The results of the present study clearly demonstrate the significant attenuation of ACh-induced vasodilation of small radial uteroplacental arteries from diabetic pregnant rats. In contrast, both maximal responses and sensitivity to ACh were unchanged in the main uterine artery from pregnant mice with STZ-induced diabetes (63) . Inhibition of NO and prostacyclin production in this vessel revealed a significantly blunted EDHF-dependent relaxation. These findings suggest that in the main uterine artery of diabetic pregnant mice, NO production can effectively compensate for reduced EDHF mechanism (63) . Available experimental data provide evidence that in large systemic arteries, endothelium-mediated vasodilation mostly relies on NO production. For example, NO is the major mediator of endothelium-dependent dilation in the femoral artery (66) . Endothelial function of these vessels was mostly preserved in diabetic male rats. In contrast, EDHF-mediated vasodilation is prominent in the mesenteric resistance vasculature, and it was markedly reduced in the same diabetic model (66) . Previously, we (33) have shown a predominance of the EDHF mechanism in endothelium-dependent vasodilation of radial uteroplacental arteries. In the present study, EDHF-mediated vasodilation was almost abolished by diabetes (Fig. 3) . We concluded that EDHF is exceptionally sensitive to diabetic damage and that impaired EDHF is a key mechanism responsible for uteroplacental endothelial dysfunction in rat diabetic pregnancy. An important implication of these findings is that endothelial function of small resistance uterine arteries may be more vulnerable to the damaging effects of diabetes compared with large uterine vessels.
A decrease in SMC [Ca 2ϩ ] i and reduction in sensitivity to intracellular Ca 2ϩ are two major mechanisms that account for the vascular dilatation in the macro-and microcirculation. Both mechanisms are importantly involved in the regulation of vascular tone and can be significantly altered under various pathological states (19) . Our data demonstrate that impaired ACh-induced vasodilation in diabetes was associated with significantly blunted SMC [Ca 2ϩ ] i responses (Fig. 1) . AChinduced SMC hyperpolarization was also decreased in diabetic vessels. As evident from the representative records shown in Figs. 1 and 5 , the pattern of Ca 2ϩ transients (Ca 2ϩ waves with superimposed fast Ca 2ϩ spikes) was identical to that of electrical activity (waves of membrane potential with superimposed fast spikes), revealing a close association between SMC electrical activity and Ca 2ϩ handling. Our findings demonstrate that inhibition of ACh-induced hyperpolarization is one of the essential mechanisms of impaired uterine vasodilation in diabetic pregnancy. Similarly, ACh-induced hyperpolarization was significantly diminished in mesenteric and carotid arteries of diabetic rats (29, 42, 66) . Therefore, impaired agonistinduced hyperpolarization may be a common mechanism contributing to diabetes-induced endothelial dysfunction in various vascular beds.
In maternal uterine arteries, diabetes may impair AChinduced SMC hyperpolarization via reduced production of endothelium-derived relaxing factors as well as alterations of cellular pathways leading to EC and/or SMC hyperpolarization. An increase in [Ca 2ϩ ] i is a specific mechanism that translates the effects of mechanical or agonist stimulation of ECs into cellular responses. In maternal uterine arteries, intracellular chelation of endothelial [Ca 2ϩ ] i with BAPTA abolished ACh-induced vasodilation, implicating [Ca 2ϩ ] i rise as a critical step in the generation of both NO and EDHF (32 ] i is one of the essential mechanisms of pregnancyenhanced basal production of endothelium-derived relaxing factors (8) . In the present study, we found that basal levels of EC [Ca 2ϩ ] i are significantly reduced by diabetes and may contribute to the attenuated endothelial influence on maternal uterine vascular tone in diabetic pregnancy. Collectively, our data demonstrate that impaired endothelial Ca 2ϩ signaling is an essential mechanism underlying endothelial dysfunction in the maternal uterine resistance vasculature during experimental diabetes.
We also noticed that basal levels of [Ca 2ϩ ] i in EC sheets were significantly lower compared with those in pressurized vessels. ECs in the walls of blood vessels are subjected to mechanical forces, such as pressure-induced distension and shear stress, that can stimulate Ca 2ϩ influx through Ca 2ϩ -permeable channels, playing an important role in the production and release of endothelium-derived autacoids (3, 26, 69) . Mechanical load in isolated EC sheets is minimal, providing a potential explanation for the low basal levels of EC [Ca 2ϩ ] i . On the other hand, two-way communications between ECs and SMCs in the walls of blood vessels are well documented (49, 53) . IP 3 generated in SMCs of pressurized arteries can diffuse to ECs through gap junctions of myoendothelial projections, resulting in Ca 2ϩ release from the endoplasmic reticulum (ER) and hyperpolarization of ECs due to the activation of intermediate-conductance Ca 2ϩ -actived K ϩ (IK Ca ) channels (43, 53).
H942
The colocalization of the endothelial ER and IK Ca channels in myoendothelial projections of the mesenteric vasculature has been recently reported (48 Hyperglycemia is considered as a major causal factor of diabetes-associated endothelial dysfunction in animals and humans (20, 22, 30, 31) . However, experimental studies of hyperglycemia-evoked vascular effects have produced conflicting results. Acute treatment of cerebral or uterine arteries with high glucose was associated with enhanced endotheliumdependent vasodilation (15, 17 Accumulating data have indicated that hyperglycemia-induced endothelial mitochondrial overproduction of ROS in microvasculature activates a number of intracellular pathways resulting in impaired endothelial function (31) . One of these mechanisms is enhanced generation of diacylglycerol (DAG) and excessive PKC activation, which is a well-characterized cause of endothelial dysfunction in humans and animals with diabetes (30, 31) . A significant increase in DAG production and PKC activity in the placenta and decidua has been demonstrated in STZ-induced diabetic or transiently hyperglycemic pregnant mice. Although the cell type responsible for this phenomenon was not determined in this study, vascular cells in the decidua or placenta may be a source of increased DAG-PKC signaling (37) . PKC is a key second messenger generated in response to receptor stimulation in ECs and plays a diverse role in the regulation of EC Ca 2ϩ signaling. Recent data have demonstrated that PKC-␣ mediates ACh-induced activation of TRPV4-dependent Ca 2ϩ influx in vascular ECs (1) . On the other hand, chronic hypoxia enhances PKC-dependent inhibition of Ca 2ϩ entry in ECs of rat intrapulmonary arteries (56) . The role of enhanced PKC activity in impaired EC Ca 2ϩ signaling in uteroplacental arteries of diabetic pregnant rats requires further investigation.
In our study, EDHF-mediated vasodilation was almost abolished despite the partial preservation of EC [Ca 2ϩ ] i responses to ACh. These results suggest that, in addition to impaired endothelial Ca 2ϩ signaling, some other mechanisms contribute to the inhibition of EDHF-mediated vasodilation. EDHF was originally defined as a factor that hyperpolarizes vascular SMCs independently of NO and prostacyclin production (24) . Extensive in vivo and in vitro studies during the last decade have demonstrated an essential role of EDHF in regulating the tone of resistance arteries and arterioles in a variety of vascular beds, including uterine circulation (33, 51) . The nature of EDHF remains the matter of substantial controversy, and EDHF is no longer considered as a single endothelium-derived factor. Several diffusible substances (K ϩ , EETs, H 2 O 2 , and H 2 S) or the mechanism of myoendothelial electrical coupling have been proposed for the role of EDHF in different vascular beds. These multiple mechanisms can work separately or in a combination depending on the type of EC stimulation as well as the origin of blood vessels (for a review, see Ref. 24) .
Agonist-induced activation of endothelial SK Ca and IK Ca channels is a key mechanism of EDHF-mediated vasodilation of rat uteroplacental and human myometrial arteries (33, 51) . Consequent electrotonic spreading of hyperpolarization from ECs to adjacent SMCs and K ϩ efflux through opened SK Ca / IK Ca channels are two potential mechanisms contributing to the hyperpolarization of SMCs. Several recent studies have tested the role of altered expression of SK ca /IK Ca channels in diabetes-induced vascular dysfunction. In STZ-induced experimental diabetes, expression of these channels was reduced in cavernous tissue (70) . In contrast, impaired EDHF-mediated dilatation was associated with increased SK Ca /IK Ca channel expression in mesenteric arteries of diabetic rats (50) . These data suggest that diabetes may modulate Ca 2ϩ sensitivity/ activation and/or cellular trafficking of SK Ca /IK Ca channels in blood vessels independently of channel expression. In addition, impaired expression and/or function of connexins of myoendothelial gap junctions may play a role in the reduced EDHFmediated responses of uterine arteries in diabetic pregnancy (22) . Further studies are needed to clarify the contribution of SK Ca /IK Ca channels and connexins to endothelial dysfunction in the maternal uterine vasculature of diabetic rats.
In conclusion, the findings of the present study demonstrate that experimental diabetes during rat pregnancy results in uteroplacental endothelial dysfunction with severely impaired EDHF-mediated vasodilation. Reduced vascular SMC hyper-polarization is one of the essential mechanisms of attenuated SMC [Ca 2ϩ ] i and dilator responses of diabetic arteries to ACh. Impaired endothelial Ca 2ϩ signaling is in part responsible for endothelial dysfunction of the uterine resistance vasculature and could contribute to reduced uteroplacental blood flow in rat diabetic pregnancy. Pharmacological improvement of EC Ca 2ϩ handling may provide an important strategy for the restoration of endothelial function and enhancement of maternal uterine blood flow in human pregnancies complicated by diabetes.
